Integration of network pharmacology, transcriptomics, and experimental verification to investigate the mechanism of action of cepharanthine hydrochloride against prostate cancer
Abstract The incidence of prostate cancer (PCa) is high among elderly men. Cepharanthine hydrochloride (CH) is recognized for its important role in the prevention and treatment of various diseases. However, its effects and mechanisms of action in the context of PCa remain unclear. Our study aims to...
Saved in:
| Main Authors: | Zongming Dong, Xiaosa Chang, Xing Luo, Hui Li, Ming Deng, Zeyu Huang, Tingting Chen, Yu Chen, Bishao Sun, Yingbing Wu, Ronghua Wu, Qingjian Wu, Jingzhen Zhu, Ji Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-03004-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cepharanthine hydrochloride inhibits prostate cancer progression by modulating gut microbiota and metabolites
by: Hui Li, et al.
Published: (2025-08-01) -
Cepharanthine hydrochloride: a novel ferroptosis-inducing agent for prostate cancer treatment
by: Jing-Song Guan, et al.
Published: (2025-02-01) -
Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation
by: Fengyun Zhao, et al.
Published: (2024-11-01) -
Development and evaluation of cepharanthine-β-cyclodextrin inclusion complex oral tablets for prevention and treatment of COVID-19 lung injury
by: Di Liang, et al.
Published: (2025-07-01) -
Identification of cepharanthine as an effective inhibitor of African swine fever virus replication
by: Chuanxiang Qi, et al.
Published: (2024-12-01)